Since several years peptides have been used to investigate many aspects of the molecular mechanisms supporting the etiopathogenesis of neurological diseases. Even if well-established and commercially-available assays for the diagnosis of neurological diseases, based on peptides, are presently not available, a lot of researches has been focused to the comprehension of the pathogenetic mechanisms of relevant neurological diseases, such as Multiple Sclerosis, Alzheimer disease and prion diseases. Several peptides, which strongly contributed to increase the progress in the understanding of the molecular mechanisms of these important diseases, have been selected as antigens to be proposed in possible alternative diagnostic methodologies. The authors focused their attention on the possible peptides to be used as diagnostics for these three characteristic neurological diseases. In fact, Multiple Sclerosis is an autoimmune disease in which peptides have been used for the characterization of both B and T immune response, while Alzheimer Disease and prion diseases can be cumulative regarded as “protein folding disorders” in which peptides can be used to identify the misfolded protein.

Synthetic peptides in the diagnosis of neurological diseases / F. LOLLI; B. MAZZANTI; P. ROVERO; A.M. PAPINI. - In: CURRENT PROTEIN & PEPTIDE SCIENCE. - ISSN 1389-2037. - STAMPA. - 4:(2003), pp. 277-284. [10.2174/1389203033487162]

Synthetic peptides in the diagnosis of neurological diseases

LOLLI, FRANCESCO;B. MAZZANTI;ROVERO, PAOLO;PAPINI, ANNA MARIA
2003

Abstract

Since several years peptides have been used to investigate many aspects of the molecular mechanisms supporting the etiopathogenesis of neurological diseases. Even if well-established and commercially-available assays for the diagnosis of neurological diseases, based on peptides, are presently not available, a lot of researches has been focused to the comprehension of the pathogenetic mechanisms of relevant neurological diseases, such as Multiple Sclerosis, Alzheimer disease and prion diseases. Several peptides, which strongly contributed to increase the progress in the understanding of the molecular mechanisms of these important diseases, have been selected as antigens to be proposed in possible alternative diagnostic methodologies. The authors focused their attention on the possible peptides to be used as diagnostics for these three characteristic neurological diseases. In fact, Multiple Sclerosis is an autoimmune disease in which peptides have been used for the characterization of both B and T immune response, while Alzheimer Disease and prion diseases can be cumulative regarded as “protein folding disorders” in which peptides can be used to identify the misfolded protein.
2003
4
277
284
F. LOLLI; B. MAZZANTI; P. ROVERO; A.M. PAPINI
File in questo prodotto:
File Dimensione Formato  
CurrProtPeptSci_2003_4_277-284(Lolli).pdf

Accesso chiuso

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Tutti i diritti riservati
Dimensione 216.9 kB
Formato Adobe PDF
216.9 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/307059
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact